UB Paderborn / Katalog / Suche / in CDI

Patterns of Amphotericin B Killing Kinetics against Seven Candida Species

Antimicrobial Agents and Chemotherapy, 2004-07, Vol.48 (7), p.2477-2482

2004

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Activities of Fluconazole and Voriconazole with Terbinafine against Four Candida Species Determined by Checkerboard, Time-Kill, and Etest Methods

Antimicrobial Agents and Chemotherapy, 2005-04, Vol.49 (4), p.1593-1596

2005

Link zum Volltext

Verfügbarkeit prüfen

Kinetic Patterns of Candida albicans Germ Tube Antibody in Critically Ill Patients: Influence on Mortality

Clinical and Vaccine Immunology, 2009-10, Vol.16 (10), p.1527-1528

2009

Link zum Volltext

Verfügbarkeit prüfen

Candidemia at a tertiary-care hospital: Epidemiology, treatment, clinical outcome and risk factors for death

European journal of clinical microbiology & infectious diseases, 2002-11, Vol.21 (11), p.767-774

2002

Link zum Volltext

Verfügbarkeit prüfen

Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients

BMC infectious diseases, 2011-03, Vol.11 (1), p.60-60

2011

Link zum Volltext

Verfügbarkeit prüfen

Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?

Therapeutics and clinical risk management, 2008-12, Vol.4 (6), p.1261-1280

2008

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole in the management of nosocomial invasive fungal infections

Therapeutics and clinical risk management, 2006-06, Vol.2 (2), p.129-157

2006

Link zum Volltext

Verfügbarkeit prüfen

Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period

Diagnostic microbiology and infectious disease, 2008, Vol.60 (1), p.109-112

2008

Link zum Volltext

Verfügbarkeit prüfen

Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species

Diagnostic microbiology and infectious disease, 2003-03, Vol.45 (3), p.203-206

2003

Link zum Volltext

Verfügbarkeit prüfen

A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis

Proteomics (Weinheim), 2006-11, Vol.6 (22), p.6033-6041

2006

Link zum Volltext

Verfügbarkeit prüfen

Identification of continuous B-cell epitopes on the protein moiety of the 58-kilodalton cell wall mannoprotein of Candida albicans belonging to a family of immunodominant fungal antigens

Infection and immunity, 2001-05, Vol.69 (5), p.2909-2919

2001

Link zum Volltext

Verfügbarkeit prüfen

A proteomic-based approach for the identification ofCandida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis

Proteomics (Weinheim), 2006-11, Vol.6 (22), p.6033-6041

2006

Link zum Volltext

Verfügbarkeit prüfen

The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis

FEMS microbiology letters, 2004-03, Vol.232 (2), p.133-138

2004

Link zum Volltext

Verfügbarkeit prüfen

Identification of Continuous B-Cell Epitopes on the Protein Moiety of the 58-Kilodalton Cell Wall Mannoprotein ofCandida albicans Belonging to a Family of Immunodominant Fungal Antigens

Infection and Immunity, 2001-05, Vol.69 (5), p.2909

2001

Link zum Volltext

Verfügbarkeit prüfen

Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by national committee for clinical laboratory standards method M27-A and two other methods

Journal of clinical microbiology, 1999-07, Vol.37 (7), p.2197-2200

1999

Link zum Volltext

Verfügbarkeit prüfen

The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis

FEMS microbiology letters, 2004-03, Vol.232 (2), p.133-138

2004

Link zum Volltext

Verfügbarkeit prüfen

Fluconazole Susceptibilities of Bloodstream Candidasp. Isolates as Determined by National Committee for Clinical Laboratory Standards Method M27-A and Two Other Methods

Journal of Clinical Microbiology, 1999-07, Vol.37 (7), p.2197

1999

Link zum Volltext

Verfügbarkeit prüfen

Endocarditis infecciosa por levaduras

Enfermedades infecciosas y microbiología clínica, 2001, Vol.19 (10), p.500-502

2001

Link zum Volltext

Verfügbarkeit prüfen

Tiempo de crecimiento de levaduras en hemocultivos de monitorización continua

Enfermedades infecciosas y microbiología clínica, 2001, Vol.19 (6), p.281-282

2001

Link zum Volltext

Verfügbarkeit prüfen

Possibilities and limitations of fiscal policies as health instruments: taxes on harmful consumption. SESPAS Report 2010

Gaceta sanitaria, 2010-12, Vol.24 Suppl 1, p.85

2010

Link zum Volltext

Verfügbarkeit prüfen

Tobacco control from an economic perspective

Revista española de salud pública, 2009-01, Vol.83 (1), p.9

2009

Link zum Volltext

Verfügbarkeit prüfen

El control del tabaquismo desde la perspectiva de la economía

Revista española de salud pública, 2009, Vol.83 (1), p.9-23

2009

Link zum Volltext

Verfügbarkeit prüfen

Posibilidades y limitaciones de las políticas fiscales como instrumentos de salud: los impuestos sobre consumos nocivos. Informe SESPAS 2010

Gaceta sanitaria, 2010, Vol.24, p.85-89

2010

Link zum Volltext

Verfügbarkeit prüfen

El control del tabaquismo desde la perspectiva de la economía

Revista española de salud pública, 2009-02, Vol.83 (1)

2009

Link zum Volltext

Verfügbarkeit prüfen

El control del tabaquismo desde la perspectiva de la economía

Revista Española de Salud Pública, 2009-02, Vol.83 (1), p.9-23

2009

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Patterns of Amphotericin B Killing Kinetics against Seven Candida Species

Synergistic Activities of Fluconazole and Voriconazole with Terbinafine against Four Candida Species Determined by Checkerboard, Time-Kill, and Etest Methods

Kinetic Patterns of Candida albicans Germ Tube Antibody in Critically Ill Patients: Influence on Mortality

Candidemia at a tertiary-care hospital: Epidemiology, treatment, clinical outcome and risk factors for death

Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients

Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?

Voriconazole in the management of nosocomial invasive fungal infections

Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period

Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species

A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis

Identification of continuous B-cell epitopes on the protein moiety of the 58-kilodalton cell wall mannoprotein of Candida albicans belonging to a family of immunodominant fungal antigens

A proteomic-based approach for the identification ofCandida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis

The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis

Identification of Continuous B-Cell Epitopes on the Protein Moiety of the 58-Kilodalton Cell Wall Mannoprotein ofCandida albicans Belonging to a Family of Immunodominant Fungal Antigens

Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by national committee for clinical laboratory standards method M27-A and two other methods

The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis

Fluconazole Susceptibilities of Bloodstream Candidasp. Isolates as Determined by National Committee for Clinical Laboratory Standards Method M27-A and Two Other Methods

Endocarditis infecciosa por levaduras

Tiempo de crecimiento de levaduras en hemocultivos de monitorización continua

Possibilities and limitations of fiscal policies as health instruments: taxes on harmful consumption. SESPAS Report 2010

Tobacco control from an economic perspective

El control del tabaquismo desde la perspectiva de la economía

Posibilidades y limitaciones de las políticas fiscales como instrumentos de salud: los impuestos sobre consumos nocivos. Informe SESPAS 2010

El control del tabaquismo desde la perspectiva de la economía

El control del tabaquismo desde la perspectiva de la economía

Suchergebnisse filtern